Care pathways

Care pathways

The Patient Clinical Pathway is the whole care pathway from identification, diagnostics, and multidisciplinary case discussions to surveillance.

 

Care pathways for the following genturis are already available:

• NF2-related schwannomatosis (public version 1, 2021)
  
• non-NF2 related schwannomatosis (public version 1, 2021)
  
• Neurofibromatosis type 1 (public version 2, 2023)
  
• Lynch Syndrome (public version 2, 2023)
  
• Hereditary Breast and Ovarian Cancer syndrome (HBOC): BRCA1/BRCA2 (public version 3, 2025)
• Hereditary Breast and Ovarian Cancer syndrome (HBOC): PALB2 (public version 1, 2026)
• Hereditary Breast and Ovarian Cancer syndrome (HBOC): CHEK2 (public version 1, 2026)
  
• PTEN Hamartoma Tumour Syndrome (PHTS) (public version 1, 2021)
  
• Li-Fraumeni and heritable TP53-related cancer (hTP53rc) (public version 1, 2022)
  
• Birt-Hogg-Dubé syndrome (BHD syndrome) (public version 1, 2024)
  
• Constitutional Mismatch Repair Deficiency (CMMRD) (public version 1, 2025)

Example care pathway - NF2-related schwannomatosis